| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |